Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 21 Apr 2025 for Enfusion, Inc.. Read the official filing
Filing timeline
BuySaleBradford E. Bernstein
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Bradford E. Bernstein: trading record in brief
Bradford E. Bernstein (board member) discloses dealings in Enfusion, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 25 October 2021 and the latest from 21 April 2025.
The open-market record consists of 1 sale worth €55.8M, with no purchase. Outside the open market, there are 1 share grant.
The record was last updated on 21 April 2025 with a transaction in Enfusion, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bradford E. Bernstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
32,440,463 sharesClass A Common StockSEC:0001104659-25-036889:0
1,142,857 shares@ US$8.119513.2% of flowClass A Common StockSEC:0001104659-23-072318:0
4,075,531 shares@ US$15.89586.8% of flowClass A Common StockSEC:0001104659-22-048465:0
3 of 3 declarations
